Sindilimab combined with nab-paclitaxel plus gemcitabine as first-line treatment for patients with advanced pancreatic cancer.Huayun Zhu,Xiaofeng Sun,Xuan Pan,Pingping Wu,Jia ChenJOURNAL OF CLINICAL ONCOLOGY（2021）引用 1|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
